Cannavest Corp. (GREY:CANV)

WEB NEWS

Wednesday, January 22, 2014

Comments & Business Outlook

SAN DIEGO, Jan. 22, 2014 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC:MJNA), a leading cannabis and industrial hemp industry innovator, is pleased to inform shareholders that Company divisions continued to increase revenues significantly. With the close of the fourth quarter of 2013, the Company had a gross income of approximately $8.07 million. The most significant increase in revenue came from direct product sales through HempMedsPX, which increased revenues by over five hundred (500%) percent, or $1.06 million, with a gross income of over $1.31 million. Updates are provided for each of our portfolio companies and investments. New product launches, continued market penetration, product advertising in mainstream media and key business agreements with wholesalers, distributors and resellers of innovative industrial hemp-based cannabidiol (CBD) products are fostering exponential growth.    

Medical Marijuana Inc. is proud to announce an update on current events in advance of its official, detailed quarterly and annual reports. 

CanChew Biotechnologies – In the United States, CanChew CBD-rich hemp oil gum is available for purchase online. Each piece contains approximately 10 mg of naturally-derived industrial hemp-based cannabidiol (CBD). In the fourth quarter, the Company continued to gain market traction and public awareness while it finalized its clinical development plans. The Company is focusing on establishing celebrity and medical professional endorsements in the near future, as well as developing additional product distribution channels. In addition, CanChew Biotechnologies has established an independent board of directors and management committee. 

Canipa Holdings – Established to administer the marketing, sales, and distribution of Medical Marijuana Inc.'s portfolio of products throughout Europe and the European Free Trade Association (EFTA) participant counties. Canipa Holdings has a distribution network of pharmacies, clinics, wellness centers and retail stores in EFTA countries, and plans to offer MJNA's full line of products. The Company continued European expansion by signing additional distributors for HempMedsPX. Canipa Holdings continues to work with government officials on product approval, medical cannabis and industrial hemp approvals in Europe.

The Company has also expanded its operations to include a team dedicated to the Caribbean Islands.

HempMedsPX – HempMedsPX, a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana, Inc., was established to develop online platforms for the marketing and sales of hemp-based consumer products. The Company continues actively acquiring, developing, securing IP, adding additional online properties, and acquiring marketing and brand awareness partners. 

In order to meet the growing demand for the cannabidiol (CBD)-rich hemp oil products that HempMedsPX markets, represents and distributes, the Company increased staff in the areas of: outside sales, customer service, software and programming, website development, video production, public relations, compliance and community outreach. 

HempMedsPX launched new Cibdex and HempVĀP websites featuring hemp-based cannabidiol (CBD)-rich tincture drops and HempVĀP, the world's first hemp-based CBD vaporizer product. The full line of products that HempMedsPX represents currently includes:

CanChew

Real Scientific Hemp Oil

Cibaderm

Cibdex

HempVĀP

The Company participated in major cannabis industry events and continued its strategic marketing campaigns to increase awareness of CBD-rich hemp oil products in the public. Participating in this aggressive trade show schedule resulted in unprecedented interest in the products that HempMedsPX represents, and propelled the significant increase in revenue in the fourth quarter. Events included:

  • Miami Wholesale Expo - Miami, FL: Sept. 30-Oct. 2
  • Ohio Rights Group Tour: Oct. 10-20
  • Ultimate Women's Expo - Phoenix, AZ: Oct. 19-20
  • Champs – Denver, CO: Oct. 22-24
  • International Spa Association (ISPA) - Las Vegas NV, Mandalay Bay: Oct. 22-24
  • DPA Conference - Denver, CO: Oct. 23-26
  • LA Ultimate Women's Expo - Los Angeles, CA: Oct. 26-27
  • 2nd Annual Marijuana Business Conference & Expo - Seattle, WA: Nov 6-8
  • San Francisco Green Festival - San Francisco, CA: Nov. 9-10
  • Michigan Medical Marijuana Trade Show: Nov. 15-17
  • SOHO Natural Products Expo - Orlando FL: Dec. 5-8
  • High Times Cannabis Cup - Amsterdam, The Netherlands: Dec. 3
  • American Academy of Anti-Aging Medicine (A4M) - Las Vegas, Dec. 12-15

As part of the Company's strategic plan to increase visibility of industrial hemp-based CBD oil products with the public, the Company gained print, online, social media, television and radio coverage throughout the fourth quarter of 2013. To further awareness and brand recognition, Brand Ambassador, Cheryl Shuman, was retained in October, 2013. Awareness creation of the diverse product lines that HempMedsPX represents were featured in mainstream media including:

  • BBC
  • CNBC
  • Geraldo at Large
  • Univision
  • Fox 31 Denver
  • NBC Cincinnati
  • Robert Scott Bell radio show (archives available on iTunes, NaturalNews.com and GCN.com)
  • Danielle Lin radio show
  • Medical Jane (product reviews)
  • Ohio Free Press
  • THC Connoisseur (product review)
  • ERB magazine
  • ABC News

HempMedsPX represented the winner of the world-renowned 2013 Seattle High Times Cannabis Cup award2013 Amsterdam Cannabis Cup award, and 2013 Michigan Medical Marijuana Conference "Green Cup" contests for Highest (hemp) CBD Concentrate. 

Corporate goodwill was extended through the Company's first multi-state community outreach initiative in support of its customers, families and individuals in need. These outreach endeavors are ongoing.  

HempMedsPX continues to educate the general public that the CBD-rich hemp oil products that the company represents:

  • are available for people of all ages
  • are available for animals
  • can be purchased directly in all 50 states and in more than 40 countries

The Company is working on finalizing celebrity, medical doctor, and industry endorsements to be announced in the near future. HempMedsPX will also be featured in upcoming documentaries in the coming months.

KannaLife Sciences – KannaLife has spent years in the development of standardization in packaging for cannabis-based products. Standardization of packaging for cannabis-based products is not just a need, but a necessity. The Company looks to set the standard by which the industry will adapt and develop from. 

The Company expanded product capabilities, established additional hothouses, and finalized an agreement to access a collection of more than 100,000 extracts from plants, fungi, and bacteria. An agreement with the Natural Product Discovery Institute (NPDI), a division of the Baruch S. Blumberg Institute (BSBI), provides an opportunity for KannaLife Sciences (KannaLife) to access targeted plant species for the identification of novel phytochemicals to treat the diseases of Chronic Traumatic Encephalopathy (CTE) and Hepatic Encephalopathy (HE). This agreement is in place due to the exclusive license agreement with National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the commercialization of U.S. Patent 6,630,507, "Cannabinoids as Antioxidants and Neuroprotectants" (the "'507 Patent").

Most recently, KannaLife and Salvation Botanicals, Ltd., signed a Memorandum of Understanding centered on the standardization of botanical medicaments and patient wellness in Canada and the United States. Salvation Botanicals, Ltd. is a Canadian provider of high quality and assured botanicals in dried plant and liquid-oral based phyto-extracts. The intended joint venture between KannaLife and Salvation will focus on the expansion of the Salvation Botanicals brand in the United States and the delivery of KannaPak™ & C-Dashboard™ into the Canadian marketplace.

Red Dice Holdings – Dixie Botanicals, a brand of Red Dice Holdings, offers innovative CBD-rich hemp oil products for health conscious consumers. Formulation experts include scientists, clinical herbalists, and nutritionists who work to integrate industrial hemp oil into a variety of beneficial and uniquely effective over-the-counter (OTC) products ranging from dietary supplements to a topical balm. Red Dice Holdings also owns the Dixie Elixirs brand of products, which is one of the most prominent cannabis brands in the world, with over 80 products in 5 product categories and has been featured on 60 Minutes, National Geographic, Fox, ABC News, Fortune Magazine, Vice, The Huffington Post and many other industry and mainstream television and publications. 

Wellness Managed Services – The Company finalized a transaction that will allow for staffing and compliance management service contracts to be developed. The company will initially focus on Colorado and Arizona.

"My gratitude goes to our team and loyal shareholders for their continued support. This is an exciting time for the cannabis industry as well as for our company. It has taken years in order to prepare for product development and market positioning in this rapidly growing industry. The products that our team has developed and continues to develop are the first of their kind. We are extremely pleased that these innovative product lines are very well received by the public. As the company grows, we will continue to communicate major announcements to shareholders through news alerts and electronic newsletters," stated Michelle Sides, Chairman and Chief Operating Officer.

- See more at: http://globenewswire.com/news-release/2014/01/22/603979/10065005/en/Medical-Marijuana-Inc-4th-Quarter-2013-Corporate-Update-HempMedsPX-Has-500-Revenue-Increase-Division-and-Corporate-Holdings-Update.html#sthash.mN9lq36c.dpuf

SAN DIEGO, Jan. 22, 2014 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC:MJNA), a leading cannabis and industrial hemp industry innovator, is pleased to inform shareholders that Company divisions continued to increase revenues significantly. With the close of the fourth quarter of 2013, the Company had a gross income of approximately $8.07 million. The most significant increase in revenue came from direct product sales through HempMedsPX, which increased revenues by over five hundred (500%) percent, or $1.06 million, with a gross income of over $1.31 million. Updates are provided for each of our portfolio companies and investments. New product launches, continued market penetration, product advertising in mainstream media and key business agreements with wholesalers, distributors and resellers of innovative industrial hemp-based cannabidiol (CBD) products are fostering exponential growth.    

Medical Marijuana Inc. is proud to announce an update on current events in advance of its official, detailed quarterly and annual reports. 

CanChew Biotechnologies – In the United States, CanChew CBD-rich hemp oil gum is available for purchase online. Each piece contains approximately 10 mg of naturally-derived industrial hemp-based cannabidiol (CBD). In the fourth quarter, the Company continued to gain market traction and public awareness while it finalized its clinical development plans. The Company is focusing on establishing celebrity and medical professional endorsements in the near future, as well as developing additional product distribution channels. In addition, CanChew Biotechnologies has established an independent board of directors and management committee. 

Canipa Holdings – Established to administer the marketing, sales, and distribution of Medical Marijuana Inc.'s portfolio of products throughout Europe and the European Free Trade Association (EFTA) participant counties. Canipa Holdings has a distribution network of pharmacies, clinics, wellness centers and retail stores in EFTA countries, and plans to offer MJNA's full line of products. The Company continued European expansion by signing additional distributors for HempMedsPX. Canipa Holdings continues to work with government officials on product approval, medical cannabis and industrial hemp approvals in Europe.

The Company has also expanded its operations to include a team dedicated to the Caribbean Islands.

HempMedsPX – HempMedsPX, a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana, Inc., was established to develop online platforms for the marketing and sales of hemp-based consumer products. The Company continues actively acquiring, developing, securing IP, adding additional online properties, and acquiring marketing and brand awareness partners. 

In order to meet the growing demand for the cannabidiol (CBD)-rich hemp oil products that HempMedsPX markets, represents and distributes, the Company increased staff in the areas of: outside sales, customer service, software and programming, website development, video production, public relations, compliance and community outreach. 

HempMedsPX launched new Cibdex and HempVĀP websites featuring hemp-based cannabidiol (CBD)-rich tincture drops and HempVĀP, the world's first hemp-based CBD vaporizer product. The full line of products that HempMedsPX represents currently includes:

CanChew

Real Scientific Hemp Oil

Cibaderm

Cibdex

HempVĀP

The Company participated in major cannabis industry events and continued its strategic marketing campaigns to increase awareness of CBD-rich hemp oil products in the public. Participating in this aggressive trade show schedule resulted in unprecedented interest in the products that HempMedsPX represents, and propelled the significant increase in revenue in the fourth quarter. Events included:

  • Miami Wholesale Expo - Miami, FL: Sept. 30-Oct. 2
  • Ohio Rights Group Tour: Oct. 10-20
  • Ultimate Women's Expo - Phoenix, AZ: Oct. 19-20
  • Champs – Denver, CO: Oct. 22-24
  • International Spa Association (ISPA) - Las Vegas NV, Mandalay Bay: Oct. 22-24
  • DPA Conference - Denver, CO: Oct. 23-26
  • LA Ultimate Women's Expo - Los Angeles, CA: Oct. 26-27
  • 2nd Annual Marijuana Business Conference & Expo - Seattle, WA: Nov 6-8
  • San Francisco Green Festival - San Francisco, CA: Nov. 9-10
  • Michigan Medical Marijuana Trade Show: Nov. 15-17
  • SOHO Natural Products Expo - Orlando FL: Dec. 5-8
  • High Times Cannabis Cup - Amsterdam, The Netherlands: Dec. 3
  • American Academy of Anti-Aging Medicine (A4M) - Las Vegas, Dec. 12-15

As part of the Company's strategic plan to increase visibility of industrial hemp-based CBD oil products with the public, the Company gained print, online, social media, television and radio coverage throughout the fourth quarter of 2013. To further awareness and brand recognition, Brand Ambassador, Cheryl Shuman, was retained in October, 2013. Awareness creation of the diverse product lines that HempMedsPX represents were featured in mainstream media including:

  • BBC
  • CNBC
  • Geraldo at Large
  • Univision
  • Fox 31 Denver
  • NBC Cincinnati
  • Robert Scott Bell radio show (archives available on iTunes, NaturalNews.com and GCN.com)
  • Danielle Lin radio show
  • Medical Jane (product reviews)
  • Ohio Free Press
  • THC Connoisseur (product review)
  • ERB magazine
  • ABC News

HempMedsPX represented the winner of the world-renowned 2013 Seattle High Times Cannabis Cup award2013 Amsterdam Cannabis Cup award, and 2013 Michigan Medical Marijuana Conference "Green Cup" contests for Highest (hemp) CBD Concentrate. 

Corporate goodwill was extended through the Company's first multi-state community outreach initiative in support of its customers, families and individuals in need. These outreach endeavors are ongoing.  

HempMedsPX continues to educate the general public that the CBD-rich hemp oil products that the company represents:

  • are available for people of all ages
  • are available for animals
  • can be purchased directly in all 50 states and in more than 40 countries

The Company is working on finalizing celebrity, medical doctor, and industry endorsements to be announced in the near future. HempMedsPX will also be featured in upcoming documentaries in the coming months.

KannaLife Sciences – KannaLife has spent years in the development of standardization in packaging for cannabis-based products. Standardization of packaging for cannabis-based products is not just a need, but a necessity. The Company looks to set the standard by which the industry will adapt and develop from. 

The Company expanded product capabilities, established additional hothouses, and finalized an agreement to access a collection of more than 100,000 extracts from plants, fungi, and bacteria. An agreement with the Natural Product Discovery Institute (NPDI), a division of the Baruch S. Blumberg Institute (BSBI), provides an opportunity for KannaLife Sciences (KannaLife) to access targeted plant species for the identification of novel phytochemicals to treat the diseases of Chronic Traumatic Encephalopathy (CTE) and Hepatic Encephalopathy (HE). This agreement is in place due to the exclusive license agreement with National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the commercialization of U.S. Patent 6,630,507, "Cannabinoids as Antioxidants and Neuroprotectants" (the "'507 Patent").

Most recently, KannaLife and Salvation Botanicals, Ltd., signed a Memorandum of Understanding centered on the standardization of botanical medicaments and patient wellness in Canada and the United States. Salvation Botanicals, Ltd. is a Canadian provider of high quality and assured botanicals in dried plant and liquid-oral based phyto-extracts. The intended joint venture between KannaLife and Salvation will focus on the expansion of the Salvation Botanicals brand in the United States and the delivery of KannaPak™ & C-Dashboard™ into the Canadian marketplace.

Red Dice Holdings – Dixie Botanicals, a brand of Red Dice Holdings, offers innovative CBD-rich hemp oil products for health conscious consumers. Formulation experts include scientists, clinical herbalists, and nutritionists who work to integrate industrial hemp oil into a variety of beneficial and uniquely effective over-the-counter (OTC) products ranging from dietary supplements to a topical balm. Red Dice Holdings also owns the Dixie Elixirs brand of products, which is one of the most prominent cannabis brands in the world, with over 80 products in 5 product categories and has been featured on 60 Minutes, National Geographic, Fox, ABC News, Fortune Magazine, Vice, The Huffington Post and many other industry and mainstream television and publications. 

Wellness Managed Services – The Company finalized a transaction that will allow for staffing and compliance management service contracts to be developed. The company will initially focus on Colorado and Arizona.

"My gratitude goes to our team and loyal shareholders for their continued support. This is an exciting time for the cannabis industry as well as for our company. It has taken years in order to prepare for product development and market positioning in this rapidly growing industry. The products that our team has developed and continues to develop are the first of their kind. We are extremely pleased that these innovative product lines are very well received by the public. As the company grows, we will continue to communicate major announcements to shareholders through news alerts and electronic newsletters," stated Michelle Sides, Chairman and Chief Operating Officer.

- See more at: http://globenewswire.com/news-release/2014/01/22/603979/10065005/en/Medical-Marijuana-Inc-4th-Quarter-2013-Corporate-Update-HempMedsPX-Has-500-Revenue-Increase-Division-and-Corporate-Holdings-Update.html#sthash.mN9lq36c.dpuf

SAN DIEGO, Jan. 22, 2014 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC:MJNA), a leading cannabis and industrial hemp industry innovator, is pleased to inform shareholders that Company divisions continued to increase revenues significantly. With the close of the fourth quarter of 2013, the Company had a gross income of approximately $8.07 million. The most significant increase in revenue came from direct product sales through HempMedsPX, which increased revenues by over five hundred (500%) percent, or $1.06 million, with a gross income of over $1.31 million. Updates are provided for each of our portfolio companies and investments. New product launches, continued market penetration, product advertising in mainstream media and key business agreements with wholesalers, distributors and resellers of innovative industrial hemp-based cannabidiol (CBD) products are fostering exponential growth.    

Medical Marijuana Inc. is proud to announce an update on current events in advance of its official, detailed quarterly and annual reports. 

CanChew Biotechnologies – In the United States, CanChew CBD-rich hemp oil gum is available for purchase online. Each piece contains approximately 10 mg of naturally-derived industrial hemp-based cannabidiol (CBD). In the fourth quarter, the Company continued to gain market traction and public awareness while it finalized its clinical development plans. The Company is focusing on establishing celebrity and medical professional endorsements in the near future, as well as developing additional product distribution channels. In addition, CanChew Biotechnologies has established an independent board of directors and management committee. 

Canipa Holdings – Established to administer the marketing, sales, and distribution of Medical Marijuana Inc.'s portfolio of products throughout Europe and the European Free Trade Association (EFTA) participant counties. Canipa Holdings has a distribution network of pharmacies, clinics, wellness centers and retail stores in EFTA countries, and plans to offer MJNA's full line of products. The Company continued European expansion by signing additional distributors for HempMedsPX. Canipa Holdings continues to work with government officials on product approval, medical cannabis and industrial hemp approvals in Europe.

The Company has also expanded its operations to include a team dedicated to the Caribbean Islands.

HempMedsPX – HempMedsPX, a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana, Inc., was established to develop online platforms for the marketing and sales of hemp-based consumer products. The Company continues actively acquiring, developing, securing IP, adding additional online properties, and acquiring marketing and brand awareness partners. 

In order to meet the growing demand for the cannabidiol (CBD)-rich hemp oil products that HempMedsPX markets, represents and distributes, the Company increased staff in the areas of: outside sales, customer service, software and programming, website development, video production, public relations, compliance and community outreach. 

HempMedsPX launched new Cibdex and HempVĀP websites featuring hemp-based cannabidiol (CBD)-rich tincture drops and HempVĀP, the world's first hemp-based CBD vaporizer product. The full line of products that HempMedsPX represents currently includes:

CanChew

Real Scientific Hemp Oil

Cibaderm

Cibdex

HempVĀP

The Company participated in major cannabis industry events and continued its strategic marketing campaigns to increase awareness of CBD-rich hemp oil products in the public. Participating in this aggressive trade show schedule resulted in unprecedented interest in the products that HempMedsPX represents, and propelled the significant increase in revenue in the fourth quarter. Events included:

  • Miami Wholesale Expo - Miami, FL: Sept. 30-Oct. 2
  • Ohio Rights Group Tour: Oct. 10-20
  • Ultimate Women's Expo - Phoenix, AZ: Oct. 19-20
  • Champs – Denver, CO: Oct. 22-24
  • International Spa Association (ISPA) - Las Vegas NV, Mandalay Bay: Oct. 22-24
  • DPA Conference - Denver, CO: Oct. 23-26
  • LA Ultimate Women's Expo - Los Angeles, CA: Oct. 26-27
  • 2nd Annual Marijuana Business Conference & Expo - Seattle, WA: Nov 6-8
  • San Francisco Green Festival - San Francisco, CA: Nov. 9-10
  • Michigan Medical Marijuana Trade Show: Nov. 15-17
  • SOHO Natural Products Expo - Orlando FL: Dec. 5-8
  • High Times Cannabis Cup - Amsterdam, The Netherlands: Dec. 3
  • American Academy of Anti-Aging Medicine (A4M) - Las Vegas, Dec. 12-15

As part of the Company's strategic plan to increase visibility of industrial hemp-based CBD oil products with the public, the Company gained print, online, social media, television and radio coverage throughout the fourth quarter of 2013. To further awareness and brand recognition, Brand Ambassador, Cheryl Shuman, was retained in October, 2013. Awareness creation of the diverse product lines that HempMedsPX represents were featured in mainstream media including:

  • BBC
  • CNBC
  • Geraldo at Large
  • Univision
  • Fox 31 Denver
  • NBC Cincinnati
  • Robert Scott Bell radio show (archives available on iTunes, NaturalNews.com and GCN.com)
  • Danielle Lin radio show
  • Medical Jane (product reviews)
  • Ohio Free Press
  • THC Connoisseur (product review)
  • ERB magazine
  • ABC News

HempMedsPX represented the winner of the world-renowned 2013 Seattle High Times Cannabis Cup award2013 Amsterdam Cannabis Cup award, and 2013 Michigan Medical Marijuana Conference "Green Cup" contests for Highest (hemp) CBD Concentrate. 

Corporate goodwill was extended through the Company's first multi-state community outreach initiative in support of its customers, families and individuals in need. These outreach endeavors are ongoing.  

HempMedsPX continues to educate the general public that the CBD-rich hemp oil products that the company represents:

  • are available for people of all ages
  • are available for animals
  • can be purchased directly in all 50 states and in more than 40 countries

The Company is working on finalizing celebrity, medical doctor, and industry endorsements to be announced in the near future. HempMedsPX will also be featured in upcoming documentaries in the coming months.

KannaLife Sciences – KannaLife has spent years in the development of standardization in packaging for cannabis-based products. Standardization of packaging for cannabis-based products is not just a need, but a necessity. The Company looks to set the standard by which the industry will adapt and develop from. 

The Company expanded product capabilities, established additional hothouses, and finalized an agreement to access a collection of more than 100,000 extracts from plants, fungi, and bacteria. An agreement with the Natural Product Discovery Institute (NPDI), a division of the Baruch S. Blumberg Institute (BSBI), provides an opportunity for KannaLife Sciences (KannaLife) to access targeted plant species for the identification of novel phytochemicals to treat the diseases of Chronic Traumatic Encephalopathy (CTE) and Hepatic Encephalopathy (HE). This agreement is in place due to the exclusive license agreement with National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the commercialization of U.S. Patent 6,630,507, "Cannabinoids as Antioxidants and Neuroprotectants" (the "'507 Patent").

Most recently, KannaLife and Salvation Botanicals, Ltd., signed a Memorandum of Understanding centered on the standardization of botanical medicaments and patient wellness in Canada and the United States. Salvation Botanicals, Ltd. is a Canadian provider of high quality and assured botanicals in dried plant and liquid-oral based phyto-extracts. The intended joint venture between KannaLife and Salvation will focus on the expansion of the Salvation Botanicals brand in the United States and the delivery of KannaPak™ & C-Dashboard™ into the Canadian marketplace.

Red Dice Holdings – Dixie Botanicals, a brand of Red Dice Holdings, offers innovative CBD-rich hemp oil products for health conscious consumers. Formulation experts include scientists, clinical herbalists, and nutritionists who work to integrate industrial hemp oil into a variety of beneficial and uniquely effective over-the-counter (OTC) products ranging from dietary supplements to a topical balm. Red Dice Holdings also owns the Dixie Elixirs brand of products, which is one of the most prominent cannabis brands in the world, with over 80 products in 5 product categories and has been featured on 60 Minutes, National Geographic, Fox, ABC News, Fortune Magazine, Vice, The Huffington Post and many other industry and mainstream television and publications. 

Wellness Managed Services – The Company finalized a transaction that will allow for staffing and compliance management service contracts to be developed. The company will initially focus on Colorado and Arizona.

"My gratitude goes to our team and loyal shareholders for their continued support. This is an exciting time for the cannabis industry as well as for our company. It has taken years in order to prepare for product development and market positioning in this rapidly growing industry. The products that our team has developed and continues to develop are the first of their kind. We are extremely pleased that these innovative product lines are very well received by the public. As the company grows, we will continue to communicate major announcements to shareholders through news alerts and electronic newsletters," stated Michelle Sides, Chairman and Chief Operating Officer.

- See more at: http://globenewswire.com/news-release/2014/01/22/603979/10065005/en/Medical-Marijuana-Inc-4th-Quarter-2013-Corporate-Update-HempMedsPX-Has-500-Revenue-Increase-Division-and-Corporate-Holdings-Update.html#sthash.mN9lq36c.dpuf

SAN DIEGO, Jan. 22, 2014 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC:MJNA), a leading cannabis and industrial hemp industry innovator, is pleased to inform shareholders that Company divisions continued to increase revenues significantly. With the close of the fourth quarter of 2013, the Company had a gross income of approximately $8.07 million. The most significant increase in revenue came from direct product sales through HempMedsPX, which increased revenues by over five hundred (500%) percent, or $1.06 million, with a gross income of over $1.31 million. Updates are provided for each of our portfolio companies and investments. New product launches, continued market penetration, product advertising in mainstream media and key business agreements with wholesalers, distributors and resellers of innovative industrial hemp-based cannabidiol (CBD) products are fostering exponential growth.    

Medical Marijuana Inc. is proud to announce an update on current events in advance of its official, detailed quarterly and annual reports. 

CanChew Biotechnologies – In the United States, CanChew CBD-rich hemp oil gum is available for purchase online. Each piece contains approximately 10 mg of naturally-derived industrial hemp-based cannabidiol (CBD). In the fourth quarter, the Company continued to gain market traction and public awareness while it finalized its clinical development plans. The Company is focusing on establishing celebrity and medical professional endorsements in the near future, as well as developing additional product distribution channels. In addition, CanChew Biotechnologies has established an independent board of directors and management committee. 

Canipa Holdings – Established to administer the marketing, sales, and distribution of Medical Marijuana Inc.'s portfolio of products throughout Europe and the European Free Trade Association (EFTA) participant counties. Canipa Holdings has a distribution network of pharmacies, clinics, wellness centers and retail stores in EFTA countries, and plans to offer MJNA's full line of products. The Company continued European expansion by signing additional distributors for HempMedsPX. Canipa Holdings continues to work with government officials on product approval, medical cannabis and industrial hemp approvals in Europe.

The Company has also expanded its operations to include a team dedicated to the Caribbean Islands.

HempMedsPX – HempMedsPX, a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana, Inc., was established to develop online platforms for the marketing and sales of hemp-based consumer products. The Company continues actively acquiring, developing, securing IP, adding additional online properties, and acquiring marketing and brand awareness partners. 

In order to meet the growing demand for the cannabidiol (CBD)-rich hemp oil products that HempMedsPX markets, represents and distributes, the Company increased staff in the areas of: outside sales, customer service, software and programming, website development, video production, public relations, compliance and community outreach. 

HempMedsPX launched new Cibdex and HempVĀP websites featuring hemp-based cannabidiol (CBD)-rich tincture drops and HempVĀP, the world's first hemp-based CBD vaporizer product. The full line of products that HempMedsPX represents currently includes:

CanChew

Real Scientific Hemp Oil

Cibaderm

Cibdex

HempVĀP

The Company participated in major cannabis industry events and continued its strategic marketing campaigns to increase awareness of CBD-rich hemp oil products in the public. Participating in this aggressive trade show schedule resulted in unprecedented interest in the products that HempMedsPX represents, and propelled the significant increase in revenue in the fourth quarter. Events included:

  • Miami Wholesale Expo - Miami, FL: Sept. 30-Oct. 2
  • Ohio Rights Group Tour: Oct. 10-20
  • Ultimate Women's Expo - Phoenix, AZ: Oct. 19-20
  • Champs – Denver, CO: Oct. 22-24
  • International Spa Association (ISPA) - Las Vegas NV, Mandalay Bay: Oct. 22-24
  • DPA Conference - Denver, CO: Oct. 23-26
  • LA Ultimate Women's Expo - Los Angeles, CA: Oct. 26-27
  • 2nd Annual Marijuana Business Conference & Expo - Seattle, WA: Nov 6-8
  • San Francisco Green Festival - San Francisco, CA: Nov. 9-10
  • Michigan Medical Marijuana Trade Show: Nov. 15-17
  • SOHO Natural Products Expo - Orlando FL: Dec. 5-8
  • High Times Cannabis Cup - Amsterdam, The Netherlands: Dec. 3
  • American Academy of Anti-Aging Medicine (A4M) - Las Vegas, Dec. 12-15

As part of the Company's strategic plan to increase visibility of industrial hemp-based CBD oil products with the public, the Company gained print, online, social media, television and radio coverage throughout the fourth quarter of 2013. To further awareness and brand recognition, Brand Ambassador, Cheryl Shuman, was retained in October, 2013. Awareness creation of the diverse product lines that HempMedsPX represents were featured in mainstream media including:

  • BBC
  • CNBC
  • Geraldo at Large
  • Univision
  • Fox 31 Denver
  • NBC Cincinnati
  • Robert Scott Bell radio show (archives available on iTunes, NaturalNews.com and GCN.com)
  • Danielle Lin radio show
  • Medical Jane (product reviews)
  • Ohio Free Press
  • THC Connoisseur (product review)
  • ERB magazine
  • ABC News

HempMedsPX represented the winner of the world-renowned 2013 Seattle High Times Cannabis Cup award2013 Amsterdam Cannabis Cup award, and 2013 Michigan Medical Marijuana Conference "Green Cup" contests for Highest (hemp) CBD Concentrate. 

Corporate goodwill was extended through the Company's first multi-state community outreach initiative in support of its customers, families and individuals in need. These outreach endeavors are ongoing.  

HempMedsPX continues to educate the general public that the CBD-rich hemp oil products that the company represents:

  • are available for people of all ages
  • are available for animals
  • can be purchased directly in all 50 states and in more than 40 countries

The Company is working on finalizing celebrity, medical doctor, and industry endorsements to be announced in the near future. HempMedsPX will also be featured in upcoming documentaries in the coming months.

KannaLife Sciences – KannaLife has spent years in the development of standardization in packaging for cannabis-based products. Standardization of packaging for cannabis-based products is not just a need, but a necessity. The Company looks to set the standard by which the industry will adapt and develop from. 

The Company expanded product capabilities, established additional hothouses, and finalized an agreement to access a collection of more than 100,000 extracts from plants, fungi, and bacteria. An agreement with the Natural Product Discovery Institute (NPDI), a division of the Baruch S. Blumberg Institute (BSBI), provides an opportunity for KannaLife Sciences (KannaLife) to access targeted plant species for the identification of novel phytochemicals to treat the diseases of Chronic Traumatic Encephalopathy (CTE) and Hepatic Encephalopathy (HE). This agreement is in place due to the exclusive license agreement with National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the commercialization of U.S. Patent 6,630,507, "Cannabinoids as Antioxidants and Neuroprotectants" (the "'507 Patent").

Most recently, KannaLife and Salvation Botanicals, Ltd., signed a Memorandum of Understanding centered on the standardization of botanical medicaments and patient wellness in Canada and the United States. Salvation Botanicals, Ltd. is a Canadian provider of high quality and assured botanicals in dried plant and liquid-oral based phyto-extracts. The intended joint venture between KannaLife and Salvation will focus on the expansion of the Salvation Botanicals brand in the United States and the delivery of KannaPak™ & C-Dashboard™ into the Canadian marketplace.

- See more at: http://globenewswire.com/news-release/2014/01/22/603979/10065005/en/Medical-Marijuana-Inc-4th-Quarter-2013-Corporate-Update-HempMedsPX-Has-500-Revenue-Increase-Division-and-Corporate-Holdings-Update.html#sthash.mN9lq36c.dpuf

SAN DIEGO, Jan. 22, 2014 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC:MJNA), a leading cannabis and industrial hemp industry innovator, is pleased to inform shareholders that Company divisions continued to increase revenues significantly. With the close of the fourth quarter of 2013, the Company had a gross income of approximately $8.07 million. The most significant increase in revenue came from direct product sales through HempMedsPX, which increased revenues by over five hundred (500%) percent, or $1.06 million, with a gross income of over $1.31 million. Updates are provided for each of our portfolio companies and investments. New product launches, continued market penetration, product advertising in mainstream media and key business agreements with wholesalers, distributors and resellers of innovative industrial hemp-based cannabidiol (CBD) products are fostering exponential growth.   

Medical Marijuana Inc. is proud to announce an update on current events in advance of its official, detailed quarterly and annual reports.

CanChew Biotechnologies – In the United States, CanChew CBD-rich hemp oil gum is available for purchase online. Each piece contains approximately 10 mg of naturally-derived industrial hemp-based cannabidiol (CBD). In the fourth quarter, the Company continued to gain market traction and public awareness while it finalized its clinical development plans. The Company is focusing on establishing celebrity and medical professional endorsements in the near future, as well as developing additional product distribution channels. In addition, CanChew Biotechnologies has established an independent board of directors and management committee.

Canipa Holdings – Established to administer the marketing, sales, and distribution of Medical Marijuana Inc.'s portfolio of products throughout Europe and the European Free Trade Association (EFTA) participant counties. Canipa Holdings has a distribution network of pharmacies, clinics, wellness centers and retail stores in EFTA countries, and plans to offer MJNA's full line of products. The Company continued European expansion by signing additional distributors for HempMedsPX. Canipa Holdings continues to work with government officials on product approval, medical cannabis and industrial hemp approvals in Europe.

The Company has also expanded its operations to include a team dedicated to the Caribbean Islands.

HempMedsPX – HempMedsPX, a corporate portfolio company of Medical Marijuana Inc. and the exclusive master distributor and contracted marketing company for CannaVest Corp. and Medical Marijuana, Inc., was established to develop online platforms for the marketing and sales of hemp-based consumer products. The Company continues actively acquiring, developing, securing IP, adding additional online properties, and acquiring marketing and brand awareness partners.

In order to meet the growing demand for the cannabidiol (CBD)-rich hemp oil products that HempMedsPX markets, represents and distributes, the Company increased staff in the areas of: outside sales, customer service, software and programming, website development, video production, public relations, compliance and community outreach.

HempMedsPX launched new Cibdex and HempVĀP websites featuring hemp-based cannabidiol (CBD)-rich tincture drops and HempVĀP, the world's first hemp-based CBD vaporizer product. The full line of products that HempMedsPX represents currently includes:

CanChew

Real Scientific Hemp Oil

Cibaderm

Cibdex

HempVĀP

The Company participated in major cannabis industry events and continued its strategic marketing campaigns to increase awareness of CBD-rich hemp oil products in the public. Participating in this aggressive trade show schedule resulted in unprecedented interest in the products that HempMedsPX represents, and propelled the significant increase in revenue in the fourth quarter. Events included:

  •     Miami Wholesale Expo - Miami, FL: Sept. 30-Oct. 2
        Ohio Rights Group Tour: Oct. 10-20
        Ultimate Women's Expo - Phoenix, AZ: Oct. 19-20
        Champs – Denver, CO: Oct. 22-24
        International Spa Association (ISPA) - Las Vegas NV, Mandalay Bay: Oct. 22-24
        DPA Conference - Denver, CO: Oct. 23-26
        LA Ultimate Women's Expo - Los Angeles, CA: Oct. 26-27
        2nd Annual Marijuana Business Conference & Expo - Seattle, WA: Nov 6-8
        San Francisco Green Festival - San Francisco, CA: Nov. 9-10
        Michigan Medical Marijuana Trade Show: Nov. 15-17
        SOHO Natural Products Expo - Orlando FL: Dec. 5-8
        High Times Cannabis Cup - Amsterdam, The Netherlands: Dec. 3
        American Academy of Anti-Aging Medicine (A4M) - Las Vegas, Dec. 12-15

As part of the Company's strategic plan to increase visibility of industrial hemp-based CBD oil products with the public, the Company gained print, online, social media, television and radio coverage throughout the fourth quarter of 2013. To further awareness and brand recognition, Brand Ambassador, Cheryl Shuman, was retained in October, 2013. Awareness creation of the diverse product lines that HempMedsPX represents were featured in mainstream media including:

  •     BBC
        CNBC
        Geraldo at Large
        Univision
        Fox 31 Denver
        NBC Cincinnati
        Robert Scott Bell radio show (archives available on iTunes, NaturalNews.com and GCN.com)
        Danielle Lin radio show
        Medical Jane (product reviews)
        Ohio Free Press
        THC Connoisseur (product review)
        ERB magazine
        ABC News

HempMedsPX represented the winner of the world-renowned 2013 Seattle High Times Cannabis Cup award, 2013 Amsterdam Cannabis Cup award, and 2013 Michigan Medical Marijuana Conference "Green Cup" contests for Highest (hemp) CBD Concentrate.

Corporate goodwill was extended through the Company's first multi-state community outreach initiative in support of its customers, families and individuals in need. These outreach endeavors are ongoing. 

HempMedsPX continues to educate the general public that the CBD-rich hemp oil products that the company represents:

  •     are available for people of all ages
        are available for animals
        can be purchased directly in all 50 states and in more than 40 countries

The Company is working on finalizing celebrity, medical doctor, and industry endorsements to be announced in the near future. HempMedsPX will also be featured in upcoming documentaries in the coming months.

KannaLife Sciences – KannaLife has spent years in the development of standardization in packaging for cannabis-based products. Standardization of packaging for cannabis-based products is not just a need, but a necessity. The Company looks to set the standard by which the industry will adapt and develop from.

The Company expanded product capabilities, established additional hothouses, and finalized an agreement to access a collection of more than 100,000 extracts from plants, fungi, and bacteria. An agreement with the Natural Product Discovery Institute (NPDI), a division of the Baruch S. Blumberg Institute (BSBI), provides an opportunity for KannaLife Sciences (KannaLife) to access targeted plant species for the identification of novel phytochemicals to treat the diseases of Chronic Traumatic Encephalopathy (CTE) and Hepatic Encephalopathy (HE). This agreement is in place due to the exclusive license agreement with National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the commercialization of U.S. Patent 6,630,507, "Cannabinoids as Antioxidants and Neuroprotectants" (the "'507 Patent").

Most recently, KannaLife and Salvation Botanicals, Ltd., signed a Memorandum of Understanding centered on the standardization of botanical medicaments and patient wellness in Canada and the United States. Salvation Botanicals, Ltd. is a Canadian provider of high quality and assured botanicals in dried plant and liquid-oral based phyto-extracts. The intended joint venture between KannaLife and Salvation will focus on the expansion of the Salvation Botanicals brand in the United States and the delivery of KannaPak™ & C-Dashboard™ into the Canadian marketplace.



Market Data powered by QuoteMedia. Terms of Use